Algernon Pharmaceuticals Inc (QB) (AGNPF)
USOTC
Year End August 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Total Assets | 2.27M | 1.64M | 1.42M | 5.34M | 12.82M | 10.14M | 8.14M | 4.19M |
Total Current Assets | 1.71M | 1.47M | 1.3M | 279k | 7.74M | 4.91M | 2.83M | 340k |
Cash and Equivalents | 1.6M | 1.39M | 1.25M | 208k | 6.12M | 2.41M | 1.41M | 125k |
Total Non-Current Assets | 2.12M | 1.59M | 1.37M | 4.97M | 12.22M | 9.12M | 5.63M | 1.47M |
Total Liabilities | 150k | 48k | 57k | 366k | 607k | 1.02M | 2.52M | 2.72M |
Total Current Liabilities | 150k | 48k | 57k | 366k | 607k | 1.02M | 2.52M | 2.72M |
Total Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Equity | 2.12M | 1.59M | 1.37M | 4.97M | 12.22M | 9.12M | 5.63M | 1.47M |
Common Equity | 7.24M | 7.99M | 8.57M | 12.59M | 21.34M | 25.85M | 27.12M | 28.15M |
Retained Earnings | -7.3M | -8.69M | -8.79M | -10.13M | -17.46M | -23.55M | -25.19M | -30.79M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.